NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Glaukos Corporation (NYSE: GKOS)

 
GKOS Technical Analysis
5
As on 20th Dec 2024 GKOS STOCK Price closed @ 150.88 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 83.18 & Strong Buy for SHORT-TERM with Stoploss of 74.94 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GKOSSTOCK Price

Open 141.53 Change Price %
High 151.12 1 Day 7.14 4.97
Low 141.53 1 Week 7.99 5.59
Close 150.88 1 Month 11.55 8.29
Volume 1053966 1 Year 79.65 111.82
52 Week High 146.35 | 52 Week Low 59.53
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
SWN 7.11 -0.56%
PFE 26.36 2.29%
BACA-U 302.00 0.67%
APO 171.03 0.83%
BAC 44.17 1.82%
CCL 26.80 6.43%
F 9.88 1.44%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
VNCE 4.82 73.38%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
WE 0.50 42.86%
WE 0.50 42.86%
DMS 0.45 36.36%
USDP 0.04 33.33%
 
NYSE USA Top Losers Stocks
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
 
 
GKOS
Daily Charts
GKOS
Intraday Charts
Whats New @
Bazaartrend
GKOS
Free Analysis
 
GKOS Important Levels Intraday
RESISTANCE169.36
RESISTANCE163.43
RESISTANCE159.77
RESISTANCE156.11
SUPPORT145.65
SUPPORT141.99
SUPPORT138.33
SUPPORT132.40
 
GKOS Forecast December 2024
4th UP Forecast165.37
3rd UP Forecast160.72
2nd UP Forecast157.85
1st UP Forecast154.98
1st DOWN Forecast146.78
2nd DOWN Forecast143.91
3rd DOWN Forecast141.04
4th DOWN Forecast136.39
 
GKOS Weekly Forecast
4th UP Forecast164.93
3rd UP Forecast160.42
2nd UP Forecast157.64
1st UP Forecast154.85
1st DOWN Forecast146.91
2nd DOWN Forecast144.12
3rd DOWN Forecast141.34
4th DOWN Forecast136.83
 
GKOS Forecast2024
4th UP Forecast327.97
3rd UP Forecast271.18
2nd UP Forecast236.07
1st UP Forecast200.97
1st DOWN Forecast100.79
2nd DOWN Forecast65.69
3rd DOWN Forecast30.58
4th DOWN Forecast-26.21
 
 
GKOS Other Details
Segment EQ
Market Capital 2130170368.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
GKOS Address
GKOS
 
GKOS Latest News
 
Your Comments and Response on Glaukos Corporation
 
GKOS Business Profile
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite for use as a standalone procedure in patients with refractory glaucoma; iStent SA, a two-stent product that is designed for use as a standalone glaucoma procedure; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. Address: 229 Avenida Fabricante, San Clemente, CA, United States, 92672
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service